Galera Therapeutics (GRTX) Short Interest Ratio & Short Volume $0.04 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Galera Therapeutics Short Interest DataGalera Therapeutics (GRTX) has a short interest of 1.91 million shares, representing 5.49% of the float (the number of shares available for trading by the public). This marks a -9.91% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.1, indicating that it would take 1.1 days of the average trading volume of 67,128 shares to cover all short positions.Current Short Interest1,910,000 sharesPrevious Short Interest2,120,000 sharesChange Vs. Previous Month-9.91%Dollar Volume Sold Short$410,841.00Short Interest Ratio1.1 Days to CoverLast Record DateMay 31, 2024Outstanding Shares54,390,000 sharesFloat Size34,820,000 sharesShort Percent of Float5.49%Today's Trading Volume26,576 sharesAverage Trading Volume67,128 sharesToday's Volume Vs. Average40% Short Selling Galera Therapeutics? Sign up to receive the latest short interest report for Galera Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGRTX Short Interest Over TimeGRTX Days to Cover Over TimeGRTX Percentage of Float Shorted Over Time Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Galera Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20241,910,000 shares $410,841.00 -9.9%5.5%1.1 $0.22 5/15/20242,120,000 shares $402,800.00 -24.0%6.1%1 $0.19 4/30/20242,790,000 shares $519,777.00 +4.9%7.3%1.4 $0.19 4/15/20242,660,000 shares $406,714.00 +50.3%6.5%1.4 $0.15 3/31/20241,770,000 shares $247,800.00 -36.8%4.1%0.7 $0.14 3/15/20242,800,000 shares $591,360.00 -45.0%7.3%1.4 $0.21 Get the Latest News and Ratings for GRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galera Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/29/20245,090,000 shares $1.24 million +51.5%13.3%2.5 $0.24 2/15/20243,360,000 shares $613,200.00 -4.0%8.6%1.7 $0.18 1/31/20243,500,000 shares $626,500.00 -24.6%9.9%1.9 $0.18 1/15/20244,640,000 shares $997,600.00 +197.4%13.1%1.4 $0.22 12/31/20231,560,000 shares $226,824.00 +12.2%3.7%0.4 $0.15 12/15/20231,390,000 shares $190,430.00 +1.5%3.3%0.4 $0.14 11/30/20231,370,000 shares $195,225.00 -24.7%3.5%0.3 $0.14 11/15/20231,820,000 shares $263,172.00 -36.6%4.5%0.4 $0.14 10/31/20232,870,000 shares $278,677.00 -1.0%8.0%0.5 $0.10 10/15/20232,900,000 shares $553,900.00 -18.3%8.1%0.6 $0.19 9/30/20233,550,000 shares $621,605.00 +73.2%9.9%1 $0.18 9/15/20232,050,000 shares $386,630.00 -15.6%5.7%0.6 $0.19 8/31/20232,430,000 shares $510,300.00 -27.7%6.8%1 $0.21 8/15/20233,360,000 shares $906,864.00 +128.6%9.4%1.4 $0.27 7/31/20231,470,000 shares $3.62 million +32.4%4.2%1.7 $2.46 7/15/20231,110,000 shares $3.05 million +12.8%3.2%1.6 $2.75 6/30/2023984,000 shares $3.07 million +11.8%2.9%1.6 $3.12 6/15/2023880,500 shares $2.98 million +8.4%2.6%1.4 $3.39 5/31/2023812,600 shares $2.49 million -1.7%2.4%1.2 $3.07 5/15/2023826,900 shares $2.63 million No Change2.4%1.1 $3.18 10/31/2022610,400 shares $885,080.00 +17.4%3.4%5 $1.45 10/15/2022519,800 shares $805,690.00 -2.5%2.9%6 $1.55 9/30/2022533,100 shares $927,594.00 +4.5%2.9%6.1 $1.74 9/15/2022510,200 shares $954,074.00 +8.5%2.8%5.4 $1.87 8/31/2022470,100 shares $629,934.00 +2.0%2.6%5.1 $1.34 8/15/2022460,900 shares $672,914.00 -4.9%2.5%5.5 $1.46 7/31/2022484,800 shares $562,368.00 -0.6%2.7%4.7 $1.16 7/15/2022487,900 shares $585,480.00 -8.7%2.7%3.7 $1.20 6/30/2022534,400 shares $694,720.00 -4.0%3.0%3.8 $1.30 6/15/2022556,700 shares $823,916.00 -6.2%3.1%3.8 $1.48 5/31/2022593,500 shares $949,600.00 +11.4%3.3%3.3 $1.60 5/15/2022533,000 shares $804,830.00 -17.5%2.9%2.4 $1.51 4/30/2022645,900 shares $1.09 million +21.0%3.6%2.6 $1.69 4/15/2022534,000 shares $1.14 million +1.9%3.0%1.7 $2.13Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. 3/31/2022524,200 shares $1.25 million -8.0%N/A0 $2.38 3/15/2022569,800 shares $1.20 million -11.1%3.2%0.2 $2.10 2/28/2022640,700 shares $1.44 million +115.7%3.6%0.1 $2.24 2/15/2022297,000 shares $694,980.00 +93.7%1.7%0 $2.34 1/31/2022153,300 shares $420,042.00 -73.6%1.4%0 $2.74 1/15/2022580,700 shares $2.00 million -71.0%N/A0 $3.44 12/31/20212,000,000 shares $9.18 million +226.7%18.0%0.2 $4.59 12/15/2021612,100 shares $1.78 million -17.2%5.5%0.1 $2.90 11/30/2021739,100 shares $975,612.00 +14.6%7.1%0.2 $1.32 11/15/2021645,000 shares $1.08 million -57.6%6.2%0.2 $1.68 10/29/20211,520,000 shares $2.84 million +814.0%15.2%0.6 $1.87 10/15/2021166,300 shares $1.30 million +8.5%1.7%0.2 $7.81 9/30/2021153,300 shares $1.24 million -3.1%1.5%2.2 $8.10 9/15/2021158,200 shares $1.14 million -11.9%1.5%1.7 $7.18 8/31/2021179,600 shares $1.61 million -4.5%1.7%1.6 $8.96 8/13/2021188,100 shares $1.56 million -16.1%1.8%1.5 $8.30 7/30/2021224,200 shares $1.88 million -15.6%2.1%1.5 $8.38 7/15/2021265,600 shares $2.48 million -3.6%2.5%0.4 $9.34 6/30/2021275,500 shares $2.71 million -43.9%2.6%0.4 $9.83 6/15/2021490,900 shares $4.40 million +0.9%4.7%0.8 $8.96 5/28/2021486,600 shares $4.17 million -1.5%4.6%0.8 $8.57 5/14/2021494,000 shares $3.52 million +51.2%4.8%0.9 $7.12 4/30/2021326,700 shares $2.65 million +103.4%3.4%0.6 $8.12 4/15/2021160,600 shares $1.21 million +4.8%N/A0 $7.52 3/31/2021153,200 shares $1.28 million +6.0%1.6%2.3 $8.35 3/15/2021144,500 shares $1.59 million -2.0%1.5%2.2 $11.00 2/26/2021147,500 shares $1.55 million +13.5%1.5%2.1 $10.48 2/12/2021130,000 shares $1.54 million +12.9%1.3%1.9 $11.84 1/29/2021115,200 shares $1.22 million +25.6%1.4%1.7 $10.63 1/15/202191,700 shares $917,917.00 -18.7%1.1%1 $10.01 12/31/2020112,800 shares $1.22 million -5.7%1.4%1.5 $10.79 12/15/2020119,600 shares $1.29 million -1.0%1.4%1.3 $10.80 11/30/2020120,800 shares $1.35 million -10.8%1.5%1.5 $11.21 11/15/2020135,400 shares $1.38 million -4.1%1.6%1.8 $10.20 10/30/2020141,200 shares $1.24 million +63.8%1.7%2 $8.78 10/15/202086,200 shares $1.08 million -6.6%0.9%1.4 $12.50 9/30/202092,300 shares $834,392.00 -11.0%1.0%2.2 $9.04 9/15/2020103,700 shares $852,414.00 -8.2%1.1%2.5 $8.22 8/31/2020112,900 shares $881,749.00 -2.0%1.2%1.7 $7.81 8/14/2020115,200 shares $899,712.00 -1.5%1.2%1.6 $7.81 7/31/2020116,900 shares $813,624.00 -7.8%1.2%1.6 $6.96 7/15/2020126,800 shares $997,916.00 +4.4%1.3%1.8 $7.87 6/30/2020121,500 shares $982,935.00 -11.5%1.3%1.8 $8.09 6/15/2020137,300 shares $1.20 million +981.1%1.6%3 $8.72 5/29/202012,700 shares $132,842.00 -38.9%0.2%0.6 $10.46 5/15/202020,800 shares $228,800.00 +45.5%0.3%1.1 $11.00 4/30/202014,300 shares $206,063.00 -14.9%0.2%0.8 $14.41 4/15/202016,800 shares $176,400.00 -26.6%0.3%0.7 $10.50 3/31/202022,900 shares $292,204.00 -3.0%0.5%0.7 $12.76 3/13/202023,600 shares $242,608.00 -26.3%0.5%1 $10.28Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. 2/28/202032,000 shares $266,880.00 -21.0%0.6%0.6 $8.34 2/14/202040,500 shares $455,220.00 -12.3%0.8%0.7 $11.24 1/31/202046,200 shares $698,544.00 -10.6%0.7%0.6 $15.12 1/15/202051,700 shares $743,446.00 -8.7%0.7%0.5 $14.38 12/31/201956,600 shares $717,688.00 No Change0.9%0.5 $12.68 GRTX Short Interest - Frequently Asked Questions What is Galera Therapeutics' current short interest? Short interest is the volume of Galera Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 1,910,000 shares of GRTX short. 5.49% of Galera Therapeutics' shares are currently sold short. Learn More on Galera Therapeutics' current short interest. What is a good short interest ratio for Galera Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GRTX shares currently have a short interest ratio of 1.0. Learn More on Galera Therapeutics's short interest ratio. What is a good short interest percentage for Galera Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.49% of Galera Therapeutics' floating shares are currently sold short. Is Galera Therapeutics' short interest increasing or decreasing? Galera Therapeutics saw a decrease in short interest in May. As of May 31st, there was short interest totaling 1,910,000 shares, a decrease of 9.9% from the previous total of 2,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Galera Therapeutics' float size? Galera Therapeutics currently has issued a total of 54,390,000 shares. Some of Galera Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Galera Therapeutics currently has a public float of 34,820,000 shares. How does Galera Therapeutics' short interest compare to its competitors? 5.49% of Galera Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Galera Therapeutics: Addex Therapeutics Ltd (0.43%), RedHill Biopharma Ltd. (0.13%), Vincerx Pharma, Inc. (2.43%), Soligenix, Inc. (2.07%), Moleculin Biotech, Inc. (4.47%), Ensysce Biosciences, Inc. (43.43%), Alterity Therapeutics Limited (0.04%), Coeptis Therapeutics Holdings, Inc. (0.52%), Galecto, Inc. (0.42%), Biora Therapeutics, Inc. (4.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.43 billion), Charter Communications, Inc. ($3.54 billion), Occidental Petroleum Co. ($3.11 billion), Moderna, Inc. ($2.88 billion), General Motors ($2.62 billion), Royal Caribbean Cruises Ltd. ($2.34 billion), Coinbase Global, Inc. ($2.25 billion), Tractor Supply ($2.12 billion), Dell Technologies Inc. ($1.89 billion), and Enphase Energy, Inc. ($1.72 billion). View all of the most shorted stocks. What does it mean to sell short Galera Therapeutics stock? Short selling GRTX is an investing strategy that aims to generate trading profit from Galera Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Galera Therapeutics? A short squeeze for Galera Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GRTX, which in turn drives the price of the stock up even further. How often is Galera Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GRTX, twice per month. The most recent reporting period available is May, 31 2024. More Short Interest Resources from MarketBeat Related Companies ADXN Short Interest RDHL Short Interest VINC Short Interest SNGX Short Interest MBRX Short Interest ENSC Short Interest ATHE Short Interest COEP Short Interest GLTO Short Interest BIOR Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GRTX) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredReality Check: Are You Prepared for What's Next?Global shifts, like the alliance of BRICS nations pushing for economic independence from the U.S. dollar, and ...Allegiance Gold | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRTX Stock Alerts